A novel treatment for psoriatic arthritis: Janus kinase inhibitors

Psoriatic arthritis (PsA) is a type of chronic inflammatory arthritis which is associated with psoriasis. The early recognition and treatment for PsA are of critical importance. Janus kinase (JAK) inhibitors, as a kind of orally small molecules, have emerged as an encouraging class of drug in PsA tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Miao, Dai, Sheng-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176449/
https://www.ncbi.nlm.nih.gov/pubmed/32209886
http://dx.doi.org/10.1097/CM9.0000000000000711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176449/
https://www.ncbi.nlm.nih.gov/pubmed/32209886
http://dx.doi.org/10.1097/CM9.0000000000000711

Ejemplares similares